The weaker backdrop means the FTSE 100 index is forecast to give up all yesterday’s rise, with futures pointing to a decline ...

London stocks ended Friday in negative territory, weighed down by losses in pharmaceutical shares and a surprise slowdown in ...

GSK Plc said its blood cancer drug significantly reduced the risk of death when combined with another cancer treatment, ...

The news prompted a sell-off across the industry. In the US, shares in Pfizer and Moderna sank more than 5% in early trading, ...

UK pharma group posts ‘statistically significant’ trial results for treatment combined with Blenrep pulled in 2022 ...

Major companies like pharma giant GlaxoSmithKline (GSK) have established their largest AI teams in London. The city is a global leader in AI talent, as well as home to leading AI research centres, ...

As head of HHS, Kennedy would lead a sprawling federal department that encompasses more than 100 programs supporting medicine ...

GSK fell 3.9% and AstraZeneca shed 3.1% ... Brent oil was quoted lower at USD72.08 a barrel late on Friday afternoon, down from USD72.43 at the time of the London equities close on Thursday. Gold was ...

London stocks had popped into the black by midday on Friday but gains were marginal as pharma shares took a hit and as data ...

An estimated 828 million adults (420 women, 408 men) had diabetes in 2022, an increase of 630 million since 1990. India (212 ...

BRITISH medicine-makers had billions wiped off their values yesterday after President-elect Trump appointed a vaccine sceptic ...

Children born to mothers who take antiseizure medications to manage seizures and psychiatric conditions during pregnancy may face increased risks of neurodevelopmental conditions, according to new ...